PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease
There is hardly any doubt that video content is increasingly becoming more popular among people who are looking to get information about a range of subjects. Hence, it is no surprise that YouTube is now littered with a range of channels on almost any subject one might think of and it is no different in the case of stock market investing.
Among the many stock market investment channels that have sprung up in recent times, RichTV Live has been one of the more popular ones. The channel published videos almost every day and is well known for providing reliable information to its subscribers. Yesterday, the RichTV host conducted a live stream in which he looked into the company PharmaTher Holdings Ltd (CSE:PHRM) (OTCQB:PHRRF). RichTV Live is well known for bringing under the radar companies to the attention of its investors and this was no different.
On Monday, PharmaTher Holdings made a major announcement with regards to a key milestone. The company announced that the United States Food and Drug Administration approved the company’s application with regards to the Phase 2 clinical trial of its Investigational New Drug. It is a major development for the company and one that is likely to bring it into the radar of many investors in the coming days.
Hence, it did not come as a surprise that it had been picked up by Rich Tv. Over the past months, RichTV has provided such deep analysis of breaking news stories on a regular basis and investors are almost always provided with a complete picture about the whole thing.
The phase 2 clinical trial is going to be centered around the possibility of deploying pharmacokinetics, which are derived from ketamine, for treating levodopa-induced dyskinesia in patients with Parkinson’s disease. It is an ambitious project and could have far-reaching ramifications for PharmaTher and its long-term growth.
The Rich Tv host spoke at length about the possibilities of the trial and was also quite detailed in the thoroughness with which PharmaTher is going to approach the trial. It is now going to be interesting to see if the latest development leads to any kind of rally in the PharmaTher stock price or not.
All investors are aware of the fact that a large part of successful investing is rooted in being well informed about the markets and companies. In addition to that, the existence of the internet has ... [Read]
Nowadays investors are increasingly getting more comfortable in getting their information with regards to the stock markets from a range of sources. At this point, YouTube is among the more popular platforms due to the ... [Read]
Nowadays there are multiple online sources from which investors can get information with regards to some of the stocks that they could track at any given point in time. YouTube has now become one of ... [Read]
Investors now have a plethora of options when it comes to choosing the internet platform from which he chooses to get his own information. There are obviously a wide range of websites and platforms from ... [Read]
One of the biggest developments of the past years has been the variety of online platforms from which people can now get information about companies and stocks. Video platform YouTube has become one of the ... [Read]
There are hundreds of stocks to choose from in the stock market and there are many possibilities for each of those stocks. Hence, it is necessary for investors to be well informed before making an ... [Read]
The existence of the internet has made it a lot easier for people to get all kinds of information imaginable with regard to the stock market. YouTube has become one of the more popular platforms ... [Read]
Risks and Disclosure:
Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.
All statements and opinions expressed are the opinions of the author and not of Richtvlive.com or its officers. The author is wholly responsible for the validity of all statements. Richtvlive.com was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay Richtvlive.com to publish or syndicate this article.
Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Please see our full disclaimer here for additional details before making any investment decisions.